Company: PGEN
Filing Date: 2025-08-19
Form Type: S-3
Source: 0000950103-25-010472
Chunk: 11

Company: PRECIGEN, INC.
Filing Date: 2025-08-19
Form: S-3
Chunk 11
---
 have filed a registration statement of which this
prospectus is a part to register the offer and resale of the shares offered hereunder for sale into the public market by the selling stockholders.
Following the conversion of the Preferred Stock and Warrants to Common Stock, the shares being offered hereunder will represent approximately
48.3% of our Common Stock as of August 8, 2025, and if sold in the market all at once or at about the same time, could affect the market
price of our Common Stock during the period the registration statement remains effective and could also affect our ability to raise equity
capital.

We may issue additional shares of Common Stock or preferred stock in the future, which could cause significant dilution to all stockholders.

Our Amended and Restated Articles of Incorporation,
as amended (“Articles of Incorporation”), authorize the issuance of up to 700,000,000 shares of Common Stock and 25,000,000
shares of preferred stock, each with no par value. As of August 8, 2025, we had 297,972,920 shares of Common Stock and 79,000 shares of
Preferred Stock

<div align='center'>4</div>

outstanding. However, we may issue additional shares
of Common Stock or preferred stock in the future in connection with a financing or an acquisition. Such issuances may not require the
approval of our stockholders. In addition, certain of our outstanding rights to purchase additional shares of Common Stock or securities
convertible into our Common Stock are subject to some form of anti-dilution protection, which could result in the right to purchase significantly
more shares of Common Stock being issued or a reduction in the purchase price for any such shares or both. Any issuance of additional
shares of our Common Stock, or equity securities convertible into our Common Stock, including but not limited to, preferred stock, warrants
and options, will dilute the percentage ownership interest of all stockholders, may dilute the book value per share of our Common Stock,
may negatively impact the market price of our Common Stock, and may also negatively affect stockholders’ investments.

The conversion rate of the Preferred Stock may not be adjusted for all dilutive events that may adversely affect the market price of the Preferred Stock or the Common Stock issuable upon conversion of the Preferred Stock.

The conversion rate of the Preferred Stock is subject
to adjustment only for stock subdivisions and combinations, stock dividends and certain other transactions specified in our Articles of
Incor